PMS-812

N/A

Report date: 2024/12/03 15:10:01

Base Information

Drug NamePMS-812
Drug Alias NameS-21663
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImidazoline receptor modulatorsAdrenergic receptors alpha-2 antagonists
TargetsImidazoline receptorAdrenergic receptors alpha-2
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoires Servier
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A